Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Sep;33(9):1631–1633. doi: 10.1128/aac.33.9.1631

Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.

B A Brown 1, R J Wallace Jr 1, C W Flanagan 1, R W Wilson 1, J I Luman 1, S D Redditt 1
PMCID: PMC172719  PMID: 2510597

Abstract

We reviewed tetracycline and erythromycin disk diffusion susceptibility of 457 isolates of Branhamella catarrhalis. Four isolates were resistant to tetracycline, with MICs for two available isolates of 16 micrograms/ml. Sixteen isolates were in the moderately susceptible range for erythromycin, with an MIC for one available isolate being greater than 8 micrograms/ml. These are the first tetracycline- and (by MIC) erythromycin-resistant B. catarrhalis isolates reported from the United States.

Full text

PDF
1631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Croughan M. J., Calder M. A. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrob Agents Chemother. 1984 Sep;26(3):424–425. doi: 10.1128/aac.26.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alvarez S., Jones M., Holtsclaw-Berk S., Guarderas J., Berk S. L. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaulieu D., Ouellette M., Bergeron M. G., Roy P. H. Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B. catarrhalis strain. Plasmid. 1988 Sep;20(2):158–162. doi: 10.1016/0147-619x(88)90020-0. [DOI] [PubMed] [Google Scholar]
  4. Davies B. I., Maesen F. P. The epidemiology of respiratory tract pathogens in southern Netherlands. Eur Respir J. 1988 May;1(5):415–420. [PubMed] [Google Scholar]
  5. Doern G. V., Jones R. N. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1988 Dec;32(12):1747–1753. doi: 10.1128/aac.32.12.1747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doern G. V., Tubert T. A. In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob Agents Chemother. 1988 Feb;32(2):259–261. doi: 10.1128/aac.32.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fernández-Roblas R., Jiménez Arriero M., Rodriguez-Tudela J. L., Soriano F. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis. J Antimicrob Chemother. 1988 Dec;22(6):867–872. doi: 10.1093/jac/22.6.867. [DOI] [PubMed] [Google Scholar]
  8. Kallings I., Bengtsson S., Christensen P., Holm S. E., Lind L., Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl. 1983;39:100–105. [PubMed] [Google Scholar]
  9. Kallings I. Sensitivity of Branhamella catarrhalis to oral antibiotics. Drugs. 1986;31 (Suppl 3):17–22. doi: 10.2165/00003495-198600313-00006. [DOI] [PubMed] [Google Scholar]
  10. Kamme C. Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scand J Infect Dis. 1970;2(2):117–120. doi: 10.3109/inf.1970.2.issue-2.07. [DOI] [PubMed] [Google Scholar]
  11. Knapp J. S., Johnson S. R., Zenilman J. M., Roberts M. C., Morse S. A. High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens. Antimicrob Agents Chemother. 1988 May;32(5):765–767. doi: 10.1128/aac.32.5.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Luman I., Wilson R. W., Wallace R. J., Jr, Nash D. R. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production. Antimicrob Agents Chemother. 1986 Nov;30(5):774–776. doi: 10.1128/aac.30.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maesen F. P., Davies B. I. Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):83–86. doi: 10.2165/00003495-198600313-00018. [DOI] [PubMed] [Google Scholar]
  14. McDonald T. J., Pugh G. W., Jr Plasmid profiles of Moraxella bovis isolates. Am J Vet Res. 1986 Apr;47(4):964–966. [PubMed] [Google Scholar]
  15. Morse S. A., Johnson S. R., Biddle J. W., Roberts M. C. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother. 1986 Nov;30(5):664–670. doi: 10.1128/aac.30.5.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pollard J. A., Wallace R. J., Jr, Nash D. R., Luman J. I., Wilson R. W. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 1986;31 (Suppl 3):103–108. doi: 10.2165/00003495-198600313-00022. [DOI] [PubMed] [Google Scholar]
  17. Roberts M. C., Knapp J. S. Host range of the conjugative 25.2-megadalton tetracycline resistance plasmid from Neisseria gonorrhoeae and related species. Antimicrob Agents Chemother. 1988 Apr;32(4):488–491. doi: 10.1128/aac.32.4.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Saito A., Yamaguchi K., Shigeno Y., Kohno S., Shigeno H., Kusano N., Dotsu Y., Hara K. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections. Drugs. 1986;31 (Suppl 3):87–92. doi: 10.2165/00003495-198600313-00019. [DOI] [PubMed] [Google Scholar]
  19. Thornley P. E., Aitken J. M., Nichol G. M., Slevin N. J. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report. Drugs. 1986;31 (Suppl 3):113–114. doi: 10.2165/00003495-198600313-00024. [DOI] [PubMed] [Google Scholar]
  20. Zheng X. T., Cao Y. Beta-lactamase-producing Branhamella in Beijing, China. Pediatr Infect Dis J. 1988 Oct;7(10):744–744. doi: 10.1097/00006454-198810000-00022. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES